Small Molecules, Generics
Total Trials
12
As Lead Sponsor
7
As Collaborator
5
Total Enrollment
363
NCT02203045
Outcomes Following Tourniquet and Non-Tourniquet Assisted Total Knee Arthroplasty
Phase: N/A
Role: Collaborator
Start: Oct 31, 2012
Completion: Not specified
NCT02023281
The Effects of Exercise on Depression Symptoms Using Levels of Neurotransmitters and EEG as Markers
Start: Mar 31, 2013
Completion: May 31, 2013
NCT02693457
Outcomes Following Suction Drain and Non-suction Drain Assisted Total Knee Arthroplasty
Start: Feb 29, 2016
Completion: Dec 29, 2017
NCT03928015
Evaluation of Dronabinol For Acute Pain Following Traumatic Injury
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 1, 2019
Completion: Jun 29, 2021
NCT04186598
Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema
Start: Jan 20, 2020
Completion: Sep 13, 2023
NCT04909463
Effects of Using the Duracore Splinting Device on Patient Outcomes Related to Chest Trauma
Start: Dec 4, 2020
Completion: Jul 30, 2021
NCT04942938
Impact of Direct Current Electrical Stimulation on Spasticity Levels and Functional Muscle Use in MS
Start: Jun 20, 2021
Completion: Jul 5, 2022
NCT05317689
Comparing the Effects of Psilocin and Psilocybin in Healthy Adults
Phase: Phase 1
Start: May 26, 2022
Completion: Jul 31, 2025
NCT06378229
Psilocybin for Hospitalized Patients with Treatment-resistant Depression
Start: May 21, 2024
Completion: Dec 31, 2026
NCT05491382
Muscle and Body Temperature Responses During Uphill and Downhill Running
Start: Dec 1, 2024
NCT06608459
PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study
Start: Dec 31, 2024
Completion: Jun 30, 2027
NCT06666010
PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study
Start: Jan 31, 2025
Completion: Jul 31, 2028
Loading map...